Zoetis Q2 FY25: where the revenue came from and where it went
The whole income statement of Zoetis for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Apr 1 – Jun 30, 2025
- Reported
- Aug 5, 2025
Revenue$2.46B
+4% year over year
Gross profit$1.81B
74% margin
Operating profit$0.91B
37% margin
Net profit$0.72B
29% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 2.46 | 100% | +4% |
| Livestock | 0.64 | 26% | |
| Dermatology | 0.46 | 19% | |
| Other revenue | 0.37 | 15% | |
| Cattle | 0.32 | 13% | |
| Anti infective products | 0.22 | 9% | |
| Pain sedation | 0.22 | 9% | |
| Swine | 0.12 | 5% | |
| Animal health diagnostics | 0.11 | 4% | |
| Cost of revenue | −0.65 | 26% | |
| Gross profit | 1.81 | 74% margin | +2pp |
| SG&A | −0.62 | 25% | +0pp |
| Other | −0.29 | 12% | +0pp |
| Operating profit | 0.91 | 37% margin | +3pp |
| Tax | −0.19 | ||
| Net profit | 0.72 | 29% margin | +3pp |
98 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest